Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Rheumatology Année : 2007

Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders.

Résumé

The concepts of minimal clinically important improvement (MCII) and patient acceptable symptomatic state (PASS) could help in interpreting results of trials involving patient-reported outcomes by translating the response at the group level (change in mean scores) into more clinically meaningful information by addressing the patient level as "therapeutic success (yes/no)." The aims of the special interest group (SIG) at OMERACT 8 were to discuss specific issues concerning the MCII and PASS concepts, especially the wording of the external anchor questions used to determine the MCII and PASS estimates, and to move toward a consensus for the cutoff values to use as the MCII and PASS in the different outcome criteria. The purpose of this SIG at OMERACT 8 was to inform participants of the MCII and PASS concepts and to agree on MCII and PASS values for pain, patient global assessment, and functional impairment.
Fichier principal
Vignette du fichier
inserm-00155664_edited.pdf (127.23 Ko) Télécharger le fichier
MCII_PASS_HAL.pdf (474.25 Ko) Télécharger le fichier
Loading...

Dates et versions

inserm-00155664 , version 1 (14-09-2009)

Identifiants

  • HAL Id : inserm-00155664 , version 1
  • PUBMED : 17477485

Citer

Florence Tubach, Philippe Ravaud, Dorcas Beaton, Maarten Boers, Claire Bombardier, et al.. Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders.. Journal of Rheumatology, 2007, 34 (5), pp.1188-93. ⟨inserm-00155664⟩

Collections

INSERM UNIV-PARIS7
100 Consultations
328 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More